Comparative diagnostic accuracy of pre-test clinical probability scores for the risk stratification of patients with suspected pulmonary embolism: a systematic review and Bayesian network meta-analysis.
Ali Etemadi, Mohammadmobin Hosseini, Hamed Rafiee, Amir Mahboubi, Tara Mahmoodi, Toshiki Kuno, Yaser Jenab, Claire E Raphael, Wilbert S Aronow, Kaveh Hosseini, Jay Giri
{"title":"Comparative diagnostic accuracy of pre-test clinical probability scores for the risk stratification of patients with suspected pulmonary embolism: a systematic review and Bayesian network meta-analysis.","authors":"Ali Etemadi, Mohammadmobin Hosseini, Hamed Rafiee, Amir Mahboubi, Tara Mahmoodi, Toshiki Kuno, Yaser Jenab, Claire E Raphael, Wilbert S Aronow, Kaveh Hosseini, Jay Giri","doi":"10.1186/s12890-025-03637-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The primary evaluation of pulmonary embolism (PE) is complicated by the presence of various pre-test clinical probability scores (pCPS) with different cut-offs, all equally recommended by guidelines. This lack of consensus has led to practice variability, unnecessary imaging, and worse patient outcomes. We aim to provide more definitive insights through a holistic comparison of available pCPS.</p><p><strong>Methods: </strong>PubMed, Embase and Web of Science, and Google Scholar were searched for studies evaluating pCPS in patients clinically suspected of PE until June 2023. Risk of bias was evaluated using QUADAS-2. Included pCPS were evaluated based on their diagnostic accuracy in: (1) Ruling-out PE (2) Utilization of imaging, and (3) Differentiating between patients needing d-dimer from imaging. Diagnostic test accuracy indices were synthesized using beta-binomial Bayesian methods.</p><p><strong>Results: </strong>Forty studies (37,027 patients) were included in the meta-analysis. Three-tier revised Geneva (RG) and three-tier Wells performed similarly in ruling-out PE (negative likelihood ratio (LR-) [95% credible interval (CI)]: 0·39[0·27-0·58] vs 0·34[0·25-0·45]). However, RG performed better in utilization of imaging (LR + : 6·65[3·75-10·56] vs 5·59[3·7-8·37], p < 0.001) and differentiating between patients needing d-dimer vs imaging (diagnostic odds ratio (DOR): 8·03[4·35-14·1] vs. 7·4[4·65-11·84], p < 0.001). The two-tier Wells score underperformed in all aspects (LR-: 0·56[0·45-0·68], LR + : 2·43[1·81-3·07], DOR: 4·41[2·81-6·43]). PERC demonstrated a reliable point estimate for ruling out PE, albeit with a wide CI (LR-: 0·36[0·17-0·78]).</p><p><strong>Conclusions: </strong>RG outperforms other pCPS for primary evaluation of suspected PE. While the difference is not large, RG's independence from subjective items supports its recommendation over three-tier Wells. Two-tier Wells underperforms significantly compared to the rest of pCPS. PERC shows considerable promise for minimizing unnecessary D-dimer testing in crowded emergency departments; however, more evidence is needed before its definitive recommendation.</p><p><strong>Protocol registration: </strong>PROSPERO (CRD42023464118).</p>","PeriodicalId":9148,"journal":{"name":"BMC Pulmonary Medicine","volume":"25 1","pages":"162"},"PeriodicalIF":2.6000,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Pulmonary Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12890-025-03637-6","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The primary evaluation of pulmonary embolism (PE) is complicated by the presence of various pre-test clinical probability scores (pCPS) with different cut-offs, all equally recommended by guidelines. This lack of consensus has led to practice variability, unnecessary imaging, and worse patient outcomes. We aim to provide more definitive insights through a holistic comparison of available pCPS.
Methods: PubMed, Embase and Web of Science, and Google Scholar were searched for studies evaluating pCPS in patients clinically suspected of PE until June 2023. Risk of bias was evaluated using QUADAS-2. Included pCPS were evaluated based on their diagnostic accuracy in: (1) Ruling-out PE (2) Utilization of imaging, and (3) Differentiating between patients needing d-dimer from imaging. Diagnostic test accuracy indices were synthesized using beta-binomial Bayesian methods.
Results: Forty studies (37,027 patients) were included in the meta-analysis. Three-tier revised Geneva (RG) and three-tier Wells performed similarly in ruling-out PE (negative likelihood ratio (LR-) [95% credible interval (CI)]: 0·39[0·27-0·58] vs 0·34[0·25-0·45]). However, RG performed better in utilization of imaging (LR + : 6·65[3·75-10·56] vs 5·59[3·7-8·37], p < 0.001) and differentiating between patients needing d-dimer vs imaging (diagnostic odds ratio (DOR): 8·03[4·35-14·1] vs. 7·4[4·65-11·84], p < 0.001). The two-tier Wells score underperformed in all aspects (LR-: 0·56[0·45-0·68], LR + : 2·43[1·81-3·07], DOR: 4·41[2·81-6·43]). PERC demonstrated a reliable point estimate for ruling out PE, albeit with a wide CI (LR-: 0·36[0·17-0·78]).
Conclusions: RG outperforms other pCPS for primary evaluation of suspected PE. While the difference is not large, RG's independence from subjective items supports its recommendation over three-tier Wells. Two-tier Wells underperforms significantly compared to the rest of pCPS. PERC shows considerable promise for minimizing unnecessary D-dimer testing in crowded emergency departments; however, more evidence is needed before its definitive recommendation.
期刊介绍:
BMC Pulmonary Medicine is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of pulmonary and associated disorders, as well as related molecular genetics, pathophysiology, and epidemiology.